CellumedLtd Balance Sheet Health
Financial Health criteria checks 6/6
CellumedLtd has a total shareholder equity of ₩30.8B and total debt of ₩8.6B, which brings its debt-to-equity ratio to 27.9%. Its total assets and total liabilities are ₩79.2B and ₩48.4B respectively.
Key information
27.9%
Debt to equity ratio
₩8.58b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩6.99b |
| Equity | ₩30.80b |
| Total liabilities | ₩48.40b |
| Total assets | ₩79.20b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A049180's short term assets (₩57.7B) exceed its short term liabilities (₩44.3B).
Long Term Liabilities: A049180's short term assets (₩57.7B) exceed its long term liabilities (₩4.1B).
Debt to Equity History and Analysis
Debt Level: A049180's net debt to equity ratio (5.2%) is considered satisfactory.
Reducing Debt: A049180's debt to equity ratio has reduced from 57% to 27.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A049180 has sufficient cash runway for 10 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: A049180 is forecast to have sufficient cash runway for 6 months based on free cash flow estimates, but has since raised additional capital.